He has more than a decade of experience in the area of Bioinformatics, Cancer Epigenetics, Drug Resistance and Immunogenetics. Dr. Khan also worked as a Clinical research associate in the area of Transplantation biology employing NGS for HLA typing and did his postdoctoral from Taussig Cancer Institute, Cleveland Clinic, USA. Dr. Khan’s work has led to the augmentation of clinical as well as pre-clinical studies. His lab focuses on epigenetic aspects of haematological malignancies and drug discovery. He has published his work in high impact peer reviewed journals. He is the member of multiple Editorial boards in his field. He has also received numerous young investigator awards from premier scientific bodies in United States and India.